BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31569790)

  • 1. Exploring the Interactions of Ruthenium (II) Carbosilane Metallodendrimers and Precursors with Model Cell Membranes through a Dual Spin-Label Spin-Probe Technique Using EPR.
    Carloni R; Sanz Del Olmo N; Ortega P; Fattori A; Gómez R; Ottaviani MF; García-Gallego S; Cangiotti M; de la Mata FJ
    Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the antitumor activity of carbosilane Cu(ii)-metallodendrimers through their interaction with biological membrane models.
    Sanz Del Olmo N; Carloni R; Bajo AM; Ortega P; Fattori A; Gómez R; Ottaviani MF; García-Gallego S; Cangiotti M; de la Mata FJ
    Nanoscale; 2019 Jul; 11(28):13330-13342. PubMed ID: 31271405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of Functionalized PAMAM Dendrimers with Model Cell Membranes Studied via Spin-Labeling Technique.
    Carloni R; Ottaviani MF; Ficker M; Christensen JB
    J Phys Chem B; 2022 Nov; 126(46):9686-9694. PubMed ID: 36354364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexes.
    Maroto-Díaz M; Elie BT; Gómez-Sal P; Pérez-Serrano J; Gómez R; Contel M; Javier de la Mata F
    Dalton Trans; 2016 Apr; 45(16):7049-66. PubMed ID: 26990859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbosilane metallodendrimers based on copper (II) complexes: Synthesis, EPR characterization and anticancer activity.
    Sanz Del Olmo N; Maroto-Díaz M; Gómez R; Ortega P; Cangiotti M; Ottaviani MF; de la Mata FJ
    J Inorg Biochem; 2017 Dec; 177():211-218. PubMed ID: 29031179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine-Tuning the Interaction and Therapeutic Effect of Cu(II) Carbosilane Metallodendrimers in Cancer Cells: An
    Canonico B; Carloni R; Sanz Del Olmo N; Papa S; Nasoni MG; Fattori A; Cangiotti M; de la Mata FJ; Ottaviani MF; García-Gallego S
    Mol Pharm; 2020 Jul; 17(7):2691-2702. PubMed ID: 32484691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer.
    Sanz Del Olmo N; Bajo AM; Ionov M; García-Gallego S; Bryszewska M; Gómez R; Ortega P; de la Mata FJ
    Eur J Med Chem; 2020 Aug; 199():112414. PubMed ID: 32438200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug.
    Michlewska S; Kubczak M; Maroto-Díaz M; Sanz Del Olmo N; Ortega P; Shcharbin D; Gomez Ramirez R; Javier de la Mata F; Ionov M; Bryszewska M
    Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31450702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron paramagnetic resonance and transmission electron microscopy study of the interactions between asbestiform zeolite fibers and model membranes.
    Cangiotti M; Battistelli M; Salucci S; Falcieri E; Mattioli M; Giordani M; Ottaviani MF
    J Toxicol Environ Health A; 2017; 80(3):171-187. PubMed ID: 28277034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium dendrimers as carriers for anticancer siRNA.
    Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Loznikova S; Shcharbin D; Maly M; Ramirez RG; de la Mata FJ; Bryszewska M
    J Inorg Biochem; 2018 Apr; 181():18-27. PubMed ID: 29353086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium dendrimers against acute promyelocytic leukemia: 
    Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Abashkin V; Dzmitruk V; Rogalska A; Denel M; Gapinska M; Shcharbin D; Gomez Ramirez R; de la Mata FJ; Bryszewska M
    Future Med Chem; 2019 Jul; 11(14):1741-1756. PubMed ID: 31287722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphonium carbosilane dendrimers - interaction with a simple biological membrane model.
    Wrobel D; Kubikova R; Müllerová M; Strašák T; RůŽička K; Fulem M; Maly J
    Phys Chem Chem Phys; 2018 May; 20(21):14753-14764. PubMed ID: 29775190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic carbosilane dendrimers-lipid membrane interactions.
    Wrobel D; Kłys A; Ionov M; Vitovic P; Waczulikowa I; Hianik T; Gomez-Ramirez R; de la Mata J; Klajnert B; Bryszewska M
    Chem Phys Lipids; 2012 May; 165(4):401-7. PubMed ID: 22343266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of dendrimers with selected amino acids and proteins studied by continuous wave EPR and Fourier transform EPR.
    Ottaviani MF; Jockusch S; Turro NJ; Tomalia DA; Barbon A
    Langmuir; 2004 Nov; 20(23):10238-45. PubMed ID: 15518519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancer.
    Sanz Del Olmo N; Maroto-Diaz M; Quintana S; Gómez R; Holota M; Ionov M; Bryszewska M; Carmena MJ; Ortega P; Javier de la Mata F
    Eur J Med Chem; 2020 Dec; 207():112695. PubMed ID: 32882608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hydrogenated cardanol on the structure of model membranes studied by EPR and NMR.
    Santeusanio S; Attanasi OA; Majer R; Cangiotti M; Fattori A; Ottaviani MF
    Langmuir; 2013 Sep; 29(35):11118-26. PubMed ID: 23915214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative 5-doxylstearoyllecithin and 3-doxylcholestane EPR spin labeling study of phospholipid bilayer perturbation by different oxidized lecithin species.
    Megli FM; Conte E; Russo L
    Biochim Biophys Acta; 2010 Oct; 1798(10):1886-98. PubMed ID: 20599693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial Effect of Carbosilane Metallodendrimers in Planktonic Cells of Gram-Positive and Gram-Negative Bacteria and
    Llamazares C; Sanz Del Olmo N; Ortega P; Gómez R; Soliveri J; de la Mata FJ; García-Gallego S; Copa-Patiño JL
    Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31450779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organometallic dendrimers based on Ruthenium(II) N-heterocyclic carbenes and their implication as delivery systems of anticancer small interfering RNA.
    Rodríguez-Prieto T; Michlewska S; Hołota M; Ionov M; de la Mata FJ; Cano J; Bryszewska M; Gómez R
    J Inorg Biochem; 2021 Oct; 223():111540. PubMed ID: 34273717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPR characterization of gadolinium(III)-containing-PAMAM-dendrimers in the absence and in the presence of paramagnetic probes.
    Lei XG; Jockusch S; Turro NJ; Tomalia DA; Ottaviani MF
    J Colloid Interface Sci; 2008 Jun; 322(2):457-64. PubMed ID: 18439615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.